Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
140
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Deterioration of Cycloserine in Drug Susceptibility Testing of Mycobacterium

Ruibai WangState Key Laboratory for Infectious Diseases Prevention and Control, Tuberculosis Department, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2258-3599View further author information
ORCID Icon,
Xiuqin ZhaoState Key Laboratory for Infectious Diseases Prevention and Control, Tuberculosis Department, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
&
Kanglin WanState Key Laboratory for Infectious Diseases Prevention and Control, Tuberculosis Department, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
Pages 135-140 | Published online: 13 Jan 2022

References

  • World Health Organization. Global Tuberculosis Report 2019. Geneva: World Health Organization; 2019.
  • World Health Organization. WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update. Geneva: World Health Organization; 2016.
  • Khosravi AD, Mirsaeidi M, Farahani A, et al. Prevalence of nontuberculous mycobacteria and high efficacy of D-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus. Infect Drug Resist. 2018;11:2521–2532. doi:10.2147/IDR.S187554
  • Woods GL, Brown-Elliott BA, Conville PS, et al. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic, Actinomycetes; Approved Standard- Second Edition. CLSI Document M24-A2. Vol. M24-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.
  • Pasipanodya JG, Srivastava S, Gumbo T. Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy. Clin Infect Dis. 2012;55(2):169–177. doi:10.1093/cid/cis353
  • Pasipanodya JG, McIlleron H, Burger A, Wash PA, Smith P, Gumbo T. Serum drug concentrations predictive of pulmonary tuberculosis outcomes. J Infect Dis. 2013;208(9):1464–1473. doi:10.1093/infdis/jit352
  • World Health Organization. Implementing Tuberculosis Diagnostics. Policy Framework. Geneva: World Health Organization; 2015.
  • Lee J, Armstrong DT, Ssengooba W, et al. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs. Antimicrob Agents Chemother. 2014;58(1):11–18. doi:10.1128/AAC.01209-13
  • Yu X, Ma YF, Jiang GL, Chen ST, Wang GR, Huang HR. Sensititre(R) MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis. 2016;20(3):329–334. doi:10.5588/ijtld.15.0573
  • Schroder KH, Naumann L, Kroppenstedt RM, Reischl U. Mycobacterium hassiacum sp. nov., a new rapidly growing thermophilic mycobacterium. Int J Syst Bacteriol. 1997;47(1):86–91. doi:10.1099/00207713-47-1-86
  • Kaushal G, Ramirez R, Alambo D, Taupradist W, Choksi K, Sirbu C. Initial characterization of D-cycloserine for future formulation development for anxiety disorders. Drug Discov Ther. 2011;5(5):253–260. doi:10.5582/ddt.2011.v5.5.253
  • Iakhontova LF, Bruns BP, Kartseva VD, Kobzieva SN, Perevozskaia NA. Physico-chemical and sorption properties of d-cycloserine. Antibiotiki. 1969;14(3):205–210.
  • Kartseva VD, Iakhontova LF, Isaeva NL, Bruns BP. On the stability of crystalline D-cycloserine. Antibiotiki. 1967;12(9):772–775.
  • Falzon D, Jaramillo E, Schunemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011;38(3):516–528. doi:10.1183/09031936.00073611
  • Banu S, Rahman SM, Khan MS, et al. Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory. J Clin Microbiol. 2014;52(1):156–163. doi:10.1128/JCM.02378-13

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.